Core Viewpoint - Yongsheng Medical (01612) has experienced a stock price increase of over 9% following the announcement of a positive earnings forecast, with shares trading at HKD 0.94 and a transaction volume of HKD 5.3888 million [1] Group 1: Earnings Forecast - The company anticipates an unaudited consolidated profit attributable to shareholders of no less than HKD 100 million for the fiscal year ending December 31, 2025 [1] - For the fiscal year ending December 31, 2024, the audited profit attributable to shareholders is expected to be approximately HKD 69.2 million [1] Group 2: Reasons for Growth - The board attributes the significant increase in revenue to strengthened relationships with a major customer in the imaging disposable products segment and the expansion of business scale [1] - The company has achieved better economies of scale by enhancing capacity utilization and operational efficiency, leading to improved gross profit margins [1]
永胜医疗盈喜后涨超9% 预期25年度股东应占综合溢利不少于1亿港元